BG · Q2 2025 Earnings

The closing of Viterra on July 2 reframes everything: a deal that was "a long time in the making" is now an operational integration problem rather than a regulatory waiting game. Management said "Now that the combination is complete, teams are moving quickly to identify and capture cost savings...We're already moving to implement logistical and transportation efficiencies." The pivot from strategic narrative to execution narrative signals that the synergy clock is now running — but management explicitly declined to put "any new targets out there," which is unusual for a freshly-closed transformative deal and suggests integration friction is real.

The Q3 outlook is more defensive than the full-year hold implies. "We're going to have likely a weaker Q3, given the fact that we had a lot of our crush margin lock coming into the quarter...we're really looking at second half, kind of a 30-70 split of earnings." That means the EPS hold at $7.75 depends on a Q4 hockey stick — and the locks limit Bunge's ability to capture the recent crush margin rally near-term.

The R&SO commentary darkened materially. The full-year outlook for the segment moved from improvement-from-Q2-lows to "down from previous outlook," and management entertained an analyst-framed scenario where "refining margins could potentially go to zero in the US" without pushing back hard. The $400M normalized R&SO EBIT target now looks like a policy bet rather than a base case.

Hedging language was unusually heavy for a guide-hold quarter: "it's too early to tell," "it's too early to put any new targets out there," "we probably don't have any special insights" on the RVO. The vs-typical read is clear — this is a more defensive posture than is typical for M&A close announcements, where management usually leans into synergy storytelling.